S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Laser breakthrough could send stock soaring 2,467% (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Laser breakthrough could send stock soaring 2,467% (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Laser breakthrough could send stock soaring 2,467% (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
Laser breakthrough could send stock soaring 2,467% (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
NASDAQ:XFOR

X4 Pharmaceuticals (XFOR) Earnings Date, Estimates & Call Transcripts

$2.19
-0.01 (-0.45%)
(As of 06/5/2023 ET)
Compare
Today's Range
$2.17
$2.38
50-Day Range
$0.82
$2.22
52-Week Range
$0.65
$2.41
Volume
2.83 million shs
Average Volume
2.17 million shs
Market Capitalization
$267.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50

Earnings Summary

Upcoming
Earnings Date
Aug. 3Estimated
Actual EPS
(Mar. 21)
-$0.29 Missed By -$0.06
Consensus EPS
(Mar. 21)
-$0.23
Last Year's Q1 EPS
(3/17/2022)
-$1.24
Skip Charts & View Estimated and Actual Earnings Data

XFOR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XFOR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

X4 Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.26)($0.19)($0.22)
Q2 20234($0.29)($0.17)($0.22)
Q3 20234($0.23)($0.16)($0.20)
Q4 20234($0.24)($0.16)($0.20)
FY 202315($1.02)($0.68)($0.83)

XFOR Earnings Date and Information

X4 Pharmaceuticals last issued its quarterly earnings results on March 21st, 2023. The reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.23) by $0.06. X4 Pharmaceuticals has generated ($1.31) earnings per share over the last year (($1.31) diluted earnings per share). Earnings for X4 Pharmaceuticals are expected to grow in the coming year, from ($0.63) to ($0.47) per share. X4 Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off prior year's report dates.

X4 Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/3/2023
(Estimated)
        
3/21/2023Q4 2022($0.23)($0.29)($0.06)($0.29)
11/3/2022Q3 2022($0.31)($0.26)+$0.05($0.26)
8/4/2022Q2 2022($0.65)($0.60)+$0.05($0.60)
5/12/2022Q1 2022($0.62)($0.72)($0.10)($0.72)    
3/17/2022Q4 2021($0.68)($1.24)($0.56)($1.24)    
11/4/20219/30/2021($0.72)($0.76)($0.04)($0.76)    
8/3/20216/30/2021($0.73)($0.74)($0.01)($0.74)    
5/6/20213/31/2021($0.84)($1.30)($0.46)($1.30)  
3/4/202112/31/2020($0.87)($0.91)($0.04)($0.91)  
11/5/2020Q3 2020($0.74)($0.87)($0.13)($0.87)
7/30/20206/30/2020($0.70)($0.76)($0.06)($0.76)  
5/7/20203/31/2020($0.83)($0.56)+$0.27($0.56)$3.00 million  
3/12/202012/31/2019($0.83)($0.66)+$0.17($0.66)  
11/7/2019Q3 2019($0.95)($0.95)($0.68)
8/6/2019Q2 2019($0.84)($1.02)($0.18)($1.02)
5/15/2019Q1 2019($6.67)($6.67)($6.67)
11/9/2018Q3 2018($2.94)($4.56)($1.62)($4.56)
8/13/2018Q2 2018($4.80)($5.10)($0.30)($5.10)
5/10/2018Q1 2018($7.44)($4.44)+$3.00($4.44)
3/9/2018Q4 2017($18.30)($10.08)+$8.22($10.08)












X4 Pharmaceuticals Earnings - Frequently Asked Questions

When is X4 Pharmaceuticals's earnings date?

X4 Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off last year's report dates. Learn more on XFOR's earnings history.

Did X4 Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, X4 Pharmaceuticals (NASDAQ:XFOR) missed the analysts' consensus estimate of ($0.23) by $0.06 with a reported earnings per share (EPS) of ($0.29). Learn more on analysts' earnings estimate vs. XFOR's actual earnings.

How much revenue does X4 Pharmaceuticals generate each year?

X4 Pharmaceuticals (NASDAQ:XFOR) has a recorded annual revenue of $3 million.

How much profit does X4 Pharmaceuticals generate each year?

X4 Pharmaceuticals (NASDAQ:XFOR) has a recorded net income of -$93.87 million. XFOR has generated -$1.31 earnings per share over the last four quarters.

What is X4 Pharmaceuticals's EPS forecast for next year?

X4 Pharmaceuticals's earnings are expected to grow from ($0.63) per share to ($0.47) per share in the next year.

More Earnings Resources from MarketBeat

This page (NASDAQ:XFOR) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -